GenMont Biotech Incorporation
TAI: 3164.TW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yu Chin Chen
- Employees
- 147
- Headquarters
- Tainan City, Taiwan
- IPO year
- 2008
- Market cap
- NT$1.5B
- Website
- https://www.genmont.com.tw
Loading 3164…
Loading profile data…Frequently asked questions about 3164
What does GenMont Biotech Incorporation (3164.TW) do?
GenMont Biotech Incorporation engages in the research, development, production, and sale of functional probiotic products in Taiwan. The company also offers probiotics with special functions; and original formula design and manufacturing, and equipment manufacturing services on health care food, as well as cooperates in the research, production,...
Where does 3164.TW trade?
GenMont Biotech Incorporation (3164.TW) trades on the Taiwan Stock Exchange.
What sector is 3164.TW in?
GenMont Biotech Incorporation (3164.TW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of GenMont Biotech Incorporation?
Yu Chin Chen is the chief executive officer of GenMont Biotech Incorporation (3164.TW).
Where is GenMont Biotech Incorporation headquartered?
GenMont Biotech Incorporation is headquartered in Taiwan.
Does 3164.TW pay a dividend?
Yes — GenMont Biotech Incorporation (3164.TW) paid a trailing twelve-month dividend of TWD 0.80 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 3164.TW go public?
GenMont Biotech Incorporation (3164.TW) completed its initial public offering in 2008.